Free Trial

Regeneron Pharmaceuticals Top Holdings and 13F Report (2025)

About Regeneron Pharmaceuticals

Regeneron Pharmaceuticals NASDAQ: REGN has filed 13-F forms with the SEC as an investor. Regeneron Pharmaceuticals is itself a publicly traded company. For more information on Regeneron Pharmaceuticals stock, visit the Regeneron Pharmaceuticals stock profile here.

Investment Activity

  • Regeneron Pharmaceuticals has $1.49 billion in total holdings as of June 30, 2025.
  • Regeneron Pharmaceuticals owns shares of 4 different stocks, but just 1 company or ETF makes up 80% of its holdings.
  • About 0.42% of the portfolio was sold this quarter.
  • This quarter, Regeneron Pharmaceuticals has purchased 6 new stocks and bought additional shares in 0 stocks.
  • Regeneron Pharmaceuticals sold shares of 0 stocks and completely divested from 2 stocks this quarter.

Largest Holdings

Adicet Bio
$590,592
Adverum Biotechnologies, Inc.
$388,954

Sector Allocation Over Time

Map of 500 Largest Holdings ofRegeneron Pharmaceuticals

 
 
Selling
 
 
Neutral
 
 
Buying
Issuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSector
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$1,449,289,0700.0%4,444,44597.6%Medical
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
$34,734,0930.0%3,702,9952.3%Medical
Adicet Bio, Inc. stock logo
ACET
Adicet Bio
$590,5920.0%968,1830.0%Medical
Adverum Biotechnologies, Inc.
$388,9540.0%180,9090.0%Common Stock
2seventy bio, Inc. stock logo
TSVT
2seventy bio
$0$6,198,845 -100.0%00.0%Medical
Bluebird Bio, Inc.
$0$102,480 -100.0%00.0%Common Stock

Showing largest 100 holdings. View all holdings.
SEC Filings and Trading Data